Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

News
Article

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

Infection Intel: Staying Ahead with Company Updates and Product Innovations.

Infection Intel: Staying Ahead with Company Updates and Product Innovations.

Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Recent Videos
Meet the Infection Control Today Editorial Advisory Board Members: Priya Pandya-Orozco, DNP, MSN, RN, PHN, CIC.
Meet Infection Control Today's Editorial Board Member: Tommy Davis, PhD, ACHE, APIC, BLS
Fungal Disease Awareness Week
Meet Shannon Simmons, DHSc, MPH, CIC.
Meet Matthew Pullen, MD.
Clostridioides difficile  (Adobe Stock 260659307 by gaetan)
David Levine, PhD, DPT, MPH, FAPTA
Weekly Rounds with Infection Control Today
Henry Spratt, Infection Control Today's Editorial Advisory Board member
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Related Content